aspirin has been researched along with Muscular Dystrophy, Duchenne in 2 studies
Aspirin: The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5)
acetylsalicylate : A benzoate that is the conjugate base of acetylsalicylic acid, arising from deprotonation of the carboxy group.
acetylsalicylic acid : A member of the class of benzoic acids that is salicylic acid in which the hydrogen that is attached to the phenolic hydroxy group has been replaced by an acetoxy group. A non-steroidal anti-inflammatory drug with cyclooxygenase inhibitor activity.
Muscular Dystrophy, Duchenne: An X-linked recessive muscle disease caused by an inability to synthesize DYSTROPHIN, which is involved with maintaining the integrity of the sarcolemma. Muscle fibers undergo a process that features degeneration and regeneration. Clinical manifestations include proximal weakness in the first few years of life, pseudohypertrophy, cardiomyopathy (see MYOCARDIAL DISEASES), and an increased incidence of impaired mentation. Becker muscular dystrophy is a closely related condition featuring a later onset of disease (usually adolescence) and a slowly progressive course. (Adams et al., Principles of Neurology, 6th ed, p1415)
| Excerpt | Relevance | Reference |
|---|---|---|
| "We report cerebral embolism in 2 patients with Duchenne muscular dystrophy (DMD) after respiratory tract infection." | 1.48 | [Cerebral embolism in Duchenne muscular dystrophy after respiratory tract infection - Report of two cases]. ( Fujimura, H; Hasuike, Y; Matsumura, T; Saito, T; Sakoda, S, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hasuike, Y | 1 |
| Saito, T | 2 |
| Matsumura, T | 1 |
| Fujimura, H | 1 |
| Sakoda, S | 1 |
| Palladino, M | 1 |
| Gatto, I | 1 |
| Neri, V | 1 |
| Straino, S | 1 |
| Smith, RC | 1 |
| Silver, M | 1 |
| Gaetani, E | 1 |
| Marcantoni, M | 1 |
| Giarretta, I | 1 |
| Stigliano, E | 1 |
| Capogrossi, M | 1 |
| Hlatky, L | 1 |
| Landolfi, R | 1 |
| Pola, R | 1 |
2 other studies available for aspirin and Muscular Dystrophy, Duchenne
| Article | Year |
|---|---|
[Cerebral embolism in Duchenne muscular dystrophy after respiratory tract infection - Report of two cases].
Topics: Adult; Anticoagulants; Aspirin; Brain; Diffusion Magnetic Resonance Imaging; Echocardiography; Heart | 2018 |
Angiogenic impairment of the vascular endothelium: a novel mechanism and potential therapeutic target in muscular dystrophy.
Topics: Animals; Apoptosis; Aspirin; Carcinoma, Lewis Lung; Caveolin 1; Cell Movement; Cell Proliferation; C | 2013 |